BG Medicine Inc (BGMD) Financial Statements (2024 and earlier)

Company Profile

Business Address 880 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,1237,75112,786
Cash and cash equivalents4,1237,75112,786
Restricted cash and investments   390
Receivables174319395
Inventory, net of allowances, customer advances and progress billings400459447
Inventory400459447
Prepaid expense 250250
Prepaid expense and other current assets558
Other undisclosed current assets(96)56 
Total current assets:4,8518,83514,576
Noncurrent Assets
Property, plant and equipment117192197
Intangible assets, net (including goodwill)135192372
Intangible assets, net (excluding goodwill)135192372
Investments and other noncurrent assets13496
Other undisclosed noncurrent assets126  
Total noncurrent assets:378518665
TOTAL ASSETS:5,2299,35315,241
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,9723,2585,435
Interest and dividends payable 222  
Employee-related liabilities 149300776
Accounts payable6959651,110
Accrued liabilities9061,9933,549
Debt 2,9604,3533,245
Other liabilities1839143
Deferred revenue and credits   
Other undisclosed current liabilities (371)(300)(508)
Total current liabilities:4,5797,3508,315
Noncurrent Liabilities
Long-term debt and lease obligation  2,9616,612
Long-term debt, excluding current maturities  2,9616,612
Liabilities, other than long-term debt931115
Deferred revenue and credits   
Other liabilities931115
Total noncurrent liabilities:933,0726,617
Total liabilities:4,67210,42214,932
Temporary equity, carrying amount   
Equity
Equity, attributable to parent557(1,069)309
Common stock342821
Additional paid in capital161,525151,841137,377
Accumulated deficit(161,002)(152,938)(137,089)
Total equity:557(1,069)309
TOTAL LIABILITIES AND EQUITY:5,2299,35315,241

Income Statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
2,7874,0732,815
Cost of revenue
(Cost of Goods and Services Sold)
(956)(1,389)(957)
Gross profit:1,8312,6841,858
Operating expenses(9,250)(17,185)(24,586)
Other undisclosed operating income 57127 
Operating loss:(7,362)(14,374)(22,728)
Nonoperating income (expense)262242
Investment income, nonoperating 21522
Other nonoperating income (expense)24720
Interest and debt expense(728)(1,168)(1,083)
Loss from continuing operations:(8,064)(15,520)(23,769)
Loss before gain (loss) on sale of properties:(8,064)(15,520)(23,769)
Net loss:(8,064)(15,520)(23,769)
Other undisclosed net loss attributable to parent  (329) 
Net loss attributable to parent:(8,064)(15,849)(23,769)
Preferred stock dividends and other adjustments   
Net loss available to common stockholders, diluted:(8,064)(15,849)(23,769)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(8,064)(15,520)(23,769)
Comprehensive loss, net of tax, attributable to parent:(8,064)(15,520)(23,769)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: